Phibro Animal Health (NASDAQ:PAHC) Shares Down 5.1% – What’s Next?

Phibro Animal Health Co. (NASDAQ:PAHC)’s stock price was down 5.1% during trading on Tuesday . The stock traded as low as $17.11 and last traded at $17.00. Approximately 57,908 shares were traded during mid-day trading, a decline of 69% from the average daily volume of 189,139 shares. The stock had previously closed at $17.91.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Morgan Stanley boosted their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Barclays increased their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research report on Monday, February 10th. Finally, StockNews.com downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Tuesday, March 25th. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Trading Down 6.0 %

The company has a market capitalization of $681.86 million, a P/E ratio of 35.05, a PEG ratio of 0.45 and a beta of 0.63. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The stock has a fifty day moving average of $22.11 and a 200 day moving average of $22.43.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, equities research analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were issued a dividend of $0.12 per share. The ex-dividend date was Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 2.85%. Phibro Animal Health’s payout ratio is 100.00%.

Hedge Funds Weigh In On Phibro Animal Health

A number of hedge funds have recently added to or reduced their stakes in PAHC. Geode Capital Management LLC boosted its holdings in shares of Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after purchasing an additional 27,201 shares during the period. Barclays PLC lifted its holdings in shares of Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after buying an additional 29,271 shares during the period. FMR LLC grew its position in shares of Phibro Animal Health by 22.7% during the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock worth $885,000 after buying an additional 7,270 shares in the last quarter. Smith Group Asset Management LLC purchased a new position in shares of Phibro Animal Health during the fourth quarter valued at $541,000. Finally, Inspire Investing LLC bought a new stake in shares of Phibro Animal Health in the fourth quarter valued at about $791,000. 99.34% of the stock is currently owned by institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.